Adrienne M Hammill
Affiliations: | Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States |
Area:
Vascular anomalies, clinical trialsWebsite:
https://www.cincinnatichildrens.org/bio/h/adrienne-hammillGoogle:
"Adrienne Hammill"Bio:
Parents
Sign in to add mentorDenise Adams | research assistant | University of Cincinnati College of Medicine | ||
Richard H. Scheuermann | grad student | 2001 | UT Southwestern | |
(Asymmetric cell division results in differential apoptotic cell fates in a B-cell lymphoma model of tumor dormancy) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
McDaniel CG, Adams DM, Steele KE, et al. (2023) Kaposiform lymphangiomatosis: Diagnosis, pathogenesis, and treatment. Pediatric Blood & Cancer. e30219 |
Engel ER, Hammill A, Adams D, et al. (2023) Response to sirolimus in capillary lymphatic venous malformations and associated syndromes: Impact on symptomatology, quality of life, and radiographic response. Pediatric Blood & Cancer. e30215 |
Blei F, Adams D, Brandao LR, et al. (2022) It is timely and exciting that Pediatric Blood and Cancer has endorsed a supplement dedicated to Vascular Anomalies. Pediatric Blood & Cancer. e29796 |
Canaud G, Hammill AM, Adams D, et al. (2021) A review of mechanisms of disease across PIK3CA-related disorders with vascular manifestations. Orphanet Journal of Rare Diseases. 16: 306 |
Canaud G, López Gutiérrez JC, Hammill AM, et al. (2021) EPIK-P2: A prospective phase 2, double-blind, randomized, placebo-controlled study of alpelisib in pediatric and adult patients (Pts) with PIK3CA-related overgrowth spectrum (PROS). Journal of Clinical Oncology. 39: TPS3160-TPS3160 |
Eng W, Hammill AM, Adams DM. (2020) Overgrowth syndromes and new therapies. Seminars in Pediatric Surgery. 29: 150974 |
Faughnan ME, Mager JJ, Hetts SW, et al. (2020) Second International Guidelines for the Diagnosis and Management of Hereditary Hemorrhagic Telangiectasia. Annals of Internal Medicine |
Ricci KW, Chute C, Hammill AM, et al. (2020) Retrospective study of hematologic complications in patients with slow-flow vascular malformations undergoing sclerotherapy. Pediatric Blood & Cancer. e28277 |
Le Cras TD, Goines J, Lakes N, et al. (2020) Constitutively active PIK3CA mutations are expressed by lymphatic and vascular endothelial cells in capillary lymphatic venous malformation. Angiogenesis |
Shin SM, Kim HK, Crotty EJ, et al. (2020) CT Angiography Findings of Pulmonary Arteriovenous Malformations in Children and Young Adults With Hereditary Hemorrhagic Telangiectasia. Ajr. American Journal of Roentgenology. 1-8 |